Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Respiratory Syncytial Virus Therapeutics Market

Respiratory Syncytial Virus Therapeutics Market Share

  • Report ID: GMI9184
  • Published Date: Apr 2024
  • Report Format: PDF
 Download Free Sample

Respiratory Syncytial Virus Therapeutics Market Share

The respiratory syncytial virus therapeutics industry is characterized by the presence of several key players offering innovative products. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their service portfolios, and gain a competitive advantage.
 

Respiratory Syncytial Virus Therapeutics Market Companies

Prominent players operating in the industry include:

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Gilead Sciences
  • GSK plc
  • Johnson & Johnson
  • Medivir AB
  • Merck & Co., Inc
  • Pfizer Inc.
  • Sanofi
     
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Market size for respiratory syncytial virus therapeutics was USD 5.8 billion in 2023 and is expected to register 12.8% CAGR from 2024-2032 owing to the ongoing advancements in treatment, rising disease burden, growing aging population, and increased early childhood healthcare worldwide.

Respiratory syncytial virus therapeutics industry from the palivizumab segment recorded USD 3.3 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its high efficacy in preventing severe RSV infections in high-risk populations.

North America industry is expected to register 12.7% CAGR from 2024-2032 due to the presence of advanced healthcare infrastructure, including well-equipped hospitals, healthcare facilities, and research institutions in the region.

AbbVie Inc., AstraZeneca PLC, Bausch Health Companies Inc., Gilead Sciences, GSK plc, Johnson & Johnson, Medivir AB, Merck & Co., Inc, Pfizer Inc., and Sanofi, are some of the major respiratory syncytial virus therapeutics companies worldwide.

Respiratory Syncytial Virus Therapeutics Market Scope

  • Respiratory Syncytial Virus Therapeutics Market Size
  • Respiratory Syncytial Virus Therapeutics Market Trends
  • Respiratory Syncytial Virus Therapeutics Market Analysis
  • Respiratory Syncytial Virus Therapeutics Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 10
    • Tables & Figures: 150
    • Countries covered: 23
    • Pages: 110
     Download Free Sample
    ×
    Get a free sample of Respiratory Syncytial Virus Therapeutics Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.